Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thermotherapy and Miltefosine for New World Cutaneous Leishmaniasis
NCT04515186Phase 3Completed
- Sponsor
- Drugs for Neglected Diseases initiative
- Start
- Jan 2021
- Primary completion
- Nov 2023
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of miltefosine in cutaneous leishmaniasis (CL), sponsored by Drugs for Neglected Diseases initiative. Started Jan 2021; status: completed.
02
Drugs
miltefosine
03
Conditions
cutaneous leishmaniasis (CL)
Beyond the preview
Go deeper on NCT04515186.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04515186.